Fancg Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FANCG (also known as XRCC9) is a critical component of the Fanconi Anemia (FA) DNA repair pathway. As a key scaffold protein, FANCG mediates protein-protein interactions essential for FA core complex assembly and interstrand DNA crosslink (ICL) repair. The FA pathway is essential for maintaining genomic stability, and its dysfunction leads to Fanconi Anemia - a devastating autosomal recessive disorder.
...
FANCG Protein — Fanconi Anemia Group G
Introduction
Fancg Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FANCG (also known as XRCC9) is a critical component of the Fanconi Anemia (FA) DNA repair pathway. As a key scaffold protein, FANCG mediates protein-protein interactions essential for FA core complex assembly and interstrand DNA crosslink (ICL) repair. The FA pathway is essential for maintaining genomic stability, and its dysfunction leads to Fanconi Anemia - a devastating autosomal recessive disorder.
Molecular Function in the FA Pathway
The FA-BRCA pathway coordinates the repair of DNA interstrand crosslinks (ICLs), which are among the most toxic DNA lesions:
Scaffold Function: FANCG contains multiple tetratricopeptide repeat (TPR) domains that mediate interactions with FANCA, FANCF, and other FA core complex proteins. These TPR domains form a protein-binding groove essential for complex assembly.
Complex Stabilization: FANCG stabilizes the entire FA core complex on chromatin. Studies show that FANCG directly binds to FANCA and FANCF, creating a network of protein interactions.
ICL Repair Initiation: The FANCG-containing complex recognizes ICLs and initiates the repair cascade, leading to FANCD2 monoubiquitination.
Homologous Recombination: Following ICL unhooking, FANCG coordinates the recruitment of BRCA1/2 for error-free homologous recombination repair.
Structure and Domains
FANCG is a 622 amino acid protein (70 kDa) with key structural features:
Central Region: Contains nuclear localization signals (NLS)
C-terminal Domain: Mediates FANCG dimerization and interaction with FANCF
WD40 Repeats: Some variants contain additional WD40 repeats
The TPR domains adopt a right-handed superhelical structure that provides a large interaction surface for multiple FA proteins.
Role in Neurodegeneration
DNA repair deficits are increasingly recognized in neurodegenerative diseases:
Alzheimer's Disease (AD)
DNA damage accumulates in AD neurons
FA pathway proteins show altered expression in AD brain
Genomic instability contributes to neuronal dysfunction
Parkinson's Disease (PD)
Mitochondrial dysfunction in PD intersects with nuclear DNA repair
Oxidative stress impairs FA pathway function
DNA repair deficits may accelerate dopaminergic neuron loss
Amyotrophic Lateral Sclerosis (ALS)
FANCG expression altered in motor neurons
DNA repair pathways intersect with ALS mechanisms
Ataxia-Telangiectasia (A-T)
Overlap between FA and ATM pathways
Combined DNA repair deficits enhance neurodegeneration
Therapeutic Implications
Modulating the FA pathway has therapeutic potential:
Cancer Predisposition: FA patients have 700-fold increased AML risk
Chemotherapy Enhancement: FA pathway inhibitors enhance ICL-inducing chemotherapy
Synthetic Lethality: PARP inhibitors are lethal to FA-deficient cells
Neuroprotection: Enhancing FA pathway may protect neurons
Clinical Significance
FANCG mutations cause Fanconi Anemia type G (FA-G):
Hematological Manifestations: Aplastic anemia, severe pancytopenia
Cancer Risk: Acute myeloid leukemia (AML) predisposition
Physical Anomalies: Thumb anomalies, growth retardation
Neurological: Some patients show neurodegeneration
FA-G patients typically present in childhood with bone marrow failure. Allogeneic stem cell transplantation remains the only curative option for hematological manifestations.
The study of Fancg Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[@kelley2009]: [Kelley & Tinker, FA pathway and cancer (2009)](https://doi.org/10.1158/0008-5472.CAN-09-0945) [@kee2012]: [Kee & D'Andrea, FA pathway and neurodegeneration (2012)](https://doi.org/10.1002/emmm.201100198) [@thompson2020]: [Thompson & Gomendoza, FANCA structure and function (2020)](https://doi.org/10.1016/j.dnarep.2020.102872) [@niraj2017]: [Niraj et al., Fanconi Anemia and DNA repair (2017)](https://doi.org/10.1016/j.tig.2017.01.007) [@kottemann2013]: [Kottemann & Smogorzewska, Fanconi anaemia pathway (2013)](https://doi.org/10.1038/nature12292) [@meetei2005]: [Meetei et al., FA core complex assembly (2005)](https://doi.org/10.1016/j.molcel.2005.12.007) [@alpi2008]: [Alpi et al., FANCL E3 ubiquitin ligase (2008)](https://doi.org/10.1038/nrm2334)